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There were few studies of Zika virus (ZIKV), a
flavivirus, until this past year, when large epidemics in the Americas were accompanied by
unexpectedly severe clinical manifestations. Infection in pregnant women has emerged as a
major global concern because of its linkage to
congenital abnormalities including microcephaly,
spontaneous abortion, and intrauterine growth
restriction.1 In addition, ZIKV infection in other
age groups has been associated with severe neurologic disease and the Guillain–Barré syndrome.2
Transmission cycles between humans and
Aedes aegypti mosquitoes in urban settings can
cause large-scale epidemics of ZIKV infection.
Although mosquitoes clearly are the primary
cause of ZIKV outbreaks, other modes, such as
sexual transmission,3 have been reported. So far,
all cases of sexual transmission of ZIKV have
been from infected men to their partners. Viral
persistence in the testes and semen has been
described, and the window of sexual transmission remains uncertain, which has increased
the apprehension about ZIKV infection during
pregnancy.
The question of in utero transmission attained
prominence as the emergence of ZIKV in Brazil
and other parts of Latin America became associated with an increase in the number of cases of
microcephaly. Data that support vertical infection and a causal role for ZIKV in the development of congenital malformations include the
detection of ZIKV RNA or antigen in the amniotic fluid, the placenta, or the brain tissues of
fetuses or infants in whom microcephaly is diagnosed after death in utero or soon after birth.4,5
Moreover, a prospective study involving ZIKVinfected pregnant women in Brazil showed that
29% of fetuses had gestational abnormalities
including microcephaly and intrauterine growth
restriction, which in a subgroup of cases resultn engl j med 375;5

ed in fetal death.1 Apart from this evidence, the
development of an in utero animal model of
ZIKV transmission and infection was considered
to be important in order to establish causality,
satisfy the criteria for proof of teratogenicity,
and provide a means for screening candidate
vaccines and therapeutic agents.
Four recently published mouse-model studies
have addressed the causal relationship between
ZIKV infection in pregnancy and pathologic
changes in fetuses.6-9 Three of the studies introduced different ZIKV strains into pregnant mice
through peripheral inoculation routes (intra
venous, intraperitoneal, or subcutaneous),6,7,9 and
two studies inoculated ZIKV directly into the
fetal brain.8,9 All the studies established ZIKV
infection in fetuses with resultant injury to cells
in the central nervous system; one study showed
the cellular basis of transmission of ZIKV from
maternal blood to the fetus.
Flaviviruses must overcome type I interferon–
receptor signaling in order to replicate in cells;
in part, ZIKV achieves this by inducing the degradation of the STAT2 signaling molecule (a messenger protein that is downstream of the interferon receptor) in human cells. Because ZIKV
inefficiently promotes the degradation of mouse
Stat2,10 Miner et al.6 used mice that were deficient
in type I interferon–receptor signaling so that a
sufficient level of viremia could be achieved to
seed the placenta. This group inoculated a contemporary Asian ZIKV strain into the skin of
pregnant mice early in gestation (at E6.5, equivalent to the first trimester of pregnancy in humans)
and observed placental infection, injury, and insufficiency, a high rate of fetal resorption, and
fetal brain injury and neuronal-cell death. These
observations recapitulate findings in humans
that occur in some ZIKV-infected women during
the first and second trimesters of pregnancy.1
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Figure 1. Cellular Sites of Zika Virus (ZIKV) Infection in Pregnancy.
The mouse placenta comprises both maternal- and fetal-derived components, including the junctional and labyrinth zones (Panel A).
ZIKV can infect placental trophoblasts including the trophoblast giant cells, glycogen trophoblasts, and spongiotrophoblasts in the junctional zone and the mononuclear trophoblasts, maternal sinusoids, and fetal endothelial cells that line fetal capillaries in the labyrinth
zone (insets). ZIKV infects the mouse fetal brain with tropism for cells of the cerebral cortex and ventricular zone, including cortical
neural progenitor cells and radial glial cells (Panel B). ZIKV infection leads to reduced cortical layers and ventricular cavity owing to increased cell death in cortical neural progenitors and their processes, especially in the intermediate and ventricular zones (inset).
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Moreover, this group identified ZIKV RNA and
virus within trophoblasts and fetal endothelial
cells in the placenta, findings that are consistent
with a tropism for cells lining the maternal–fetal
interface and a transplacental route of infection
(Fig. 1).
Cugola et al.7 inoculated pregnant immunocompetent SJL mice through an intravenous route
with an extraordinarily high dose (1010 to 1012
plaque-forming units) of a Brazilian strain of
ZIKV. Possibly, this dose allowed some of the
virus inoculum to seed the placenta directly
without requiring much replication in peripheral
organs, where it would be expected to be inhibited by type I interferon. As in the findings of
Miner et al., they observed intrauterine growth
restriction that resulted in smaller pups at birth.
Examination of the fetal and neonatal brains
revealed a reduced number of cortical neurons
and reduced cortical-layer thickness (Fig. 1). Cellular analysis showed that neurons in the cerebral cortex, thalamus, and hypothalamus had
evidence of deterioration. In addition, this group
noted ocular abnormalities that were similar to
those that have been described in humans.11
Li et al.8 and Wu et al.9 injected contemporary
Asian ZIKV strains directly into the lateral left
ventricle of fetal brains at E13.5 (equivalent to the
late second trimester of pregnancy in humans)
and analyzed tissues before8 or after9 birth. Both
groups observed a reduction in the number of
cortical neural progenitors in the dorsal ventricular and subventricular zones, and this loss
was associated with cell death. Wu et al. also
injected ZIKV through an intraperitoneal route
into pregnant immunocompetent mice at E13.5.
They found that ZIKV could cause a transient
viremia with seeding of the placenta in a subgroup of pregnant mice. Somewhat unexpectedly,
they found ZIKV RNA in the dorsal ventricular
zone of the fetal brain but in no other brain regions. They concluded that ZIKV can cross the
fetal–placental barrier and specifically target the
cortical neural progenitors of fetal mice.
Three of the four studies suggest that ZIKV
gains access to the fetus during pregnancy after
crossing the placental barrier, which is composed of different types of trophoblasts and
ancillary cells (Fig. 1). On the basis of the mouse
models as well as recent studies of infection in
primary human cells and tissue samples,12,13 in-
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vestigators have found that ZIKV probably replicates in subgroups of trophoblasts, fetal endothelial cells, and Hofbauer placental macrophages.
Access to these cell types may be enhanced by
the binding of ZIKV to a cell-surface tyrosine
kinase receptor called AXL.8,14 Early in pregnancy,
ZIKV infection may lead to severe placental vascular damage and a reduction in fetal blood
vessels and blood flow. Alternatively, ZIKV could
cross the placental barrier without excessive
damage and spread to the fetal brain, where it
preferentially infects and injures neuronal progenitor cells. This outcome may be more typical
of infection later in pregnancy because of enhanced interferon-λ–induced innate immunity in
trophoblasts.12 Infection and death of neuroprogenitor cells could inhibit neuronal-cell differentiation, which would explain the cortical thinning, malformation of brain structures, and
microcephaly that are observed during pregnancy in humans.
Investigators must consider the differences in
morphologic, spatial, and temporal placentation
and in utero brain development in rodents and
humans. However, many elements of placental
development and trophoblast function are similar in the two species. Although the time scale
differs substantially, neuronal developmental processes in rodents and humans are remarkably
parallel. Collectively, the findings from the studies in mice support the hypothesis that infection
during pregnancy with contemporary ZIKV
strains causes placental infection and injury and
that ZIKV spreads to the fetal brain and kills
neuronal progenitor cells, which probably contributes to the microcephaly and other congenital malformations that have been observed in
human neonates. The new mouse models provide a foundation for defining mechanisms of
pathogenesis and represent a resource for determining the effects of ZIKV strain variation on
clinical manifestations and for testing candidate
therapeutic agents and vaccines.
Disclosure forms provided by the authors are available at
NEJM.org.
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